Categories of data used
The personal health data that you use relates to the following characteristics of the beneficiaries:
–
Method elements
The aim of our study is to retrospectively evaluate so-called “long survivors” (LS) patients, defined by a survival greater than one year after the start of immunotherapy, in a population of patients with BC and taken into account. load successively and homogeneously in a general pulmonology department over a period of 5 years and to try to characterize these patients from a clinical, histological and biological point of view.
–
Population concerned
Characterizations of patients with locally advanced or metastatic long-responder non-small cell lung cancer after clinically, histologically and biologically immunotherapy
–
Regulatory information
Data recipient (s)
Not specified
–
Duration of data retention for the purposes of the project
2
–
Regulatory framework
Reference methodology
Authorization number / MR: 004
–
–
Existence of automated decision making
Not specified
–
Legal basis
(1) (e) performance of a mission of public interest (2) (j) archives, scientific or historical research, or statistics
–
Transfer guarantees
Not specified
–
Sensitive variables used
Date of death (if applicable)
–
–
Rights of individuals
Patient information is sent to living patients informing them of their various rights and allowing them to oppose the use of their data.
The records of deceased patients will be reviewed to ensure that no objection to the use of their data has been expressed by patients who are alive.
–
–
